Glofitamab Combined With Lenalidomide in High Risk Patients With Relapsed or Refractory Mantle Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to MCL
Related studies linked through entity extraction aliases.
Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study
- Status
- RECRUITING
- Phase
- PHASE2
Real-world Study of Acalabrutinib
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Sonrotoclax, Zanubrutinib and CD20mab in Untreated MCL Patients
- Status
- RECRUITING
- Phase
- PHASE2
Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy
- Status
- RECRUITING
- Phase
- N/A
Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas
- Status
- TERMINATED
- Phase
- PHASE2